This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Top ETF Stories of August
by Sanghamitra Saha
Wall Street had a downbeat August with all major indexes posting losses.
Best-Performing ETF Areas of Last Week
by Sanghamitra Saha
Wall Street was downbeat last week mainly due to Federal Reserve Chair Jerome Powell's hawkish comments at the Jackson Hole economic symposium.
Best-Performing ETF Areas of Q2
by Sanghamitra Saha
Though Wall Street is in a lackluster shape in Q2, some areas like agriculture, China, U.S. dollar, U.S. consumer staples and short-term U.S. government bond ETFs stole the show.
Top ETF Stories of Fourth-Quarter 2021
by Sanghamitra Saha
The year 2021 as a whole could easily be attributed to the reopening trades after an edgy 2020 thanks to the outbreak of COVID-19 and the resultant lockdown.
Best-Performing ETFs of Fourth Quarter
by Sanghamitra Saha
Inside the top ETFs of the fourth quarter.
Best-Performing ETF Areas of November
by Sanghamitra Saha
Wall Street was on a volatile ride in the month of November. Most indexes were in the red last month on renewed COVID-19 fear.
Coffee ETF (JO) Hits New 52-Week High
by Sanghamitra Saha
The coffee ETF (JO) hit a 52-week high lately. Can it soar further?
5 Best-Performing ETFs of Last Week
by Sanghamitra Saha
While new COVID-19 restrictions overseas weighed on the broader market at the end of the week, solid retail earnings, monthly retail sales data and investors' love for technology amid the renewed lockdown fears boosted the Nasdaq meaningfully.
4 Agriculture ETF Areas At a One-Year High: Here's Why
by Sanghamitra Saha
Several agricultural commodities specifically surged lately due to weather concerns, rising demand, supply disruptions and a lower greenback.
5 Reasons for the Commodity Boom: ETFs to Play
by Sanghamitra Saha
After a decade of underperformance, commodities are experiencing a huge rally thanks to optimism over global economic growth, reflation trade, widespread vaccination, the chances of approval of more COVID-19 antiviral pills, rising consumer confidence and higher housing price.